Media

ConvaTec Rated #1 in Corporate Reputation by Patient Groups and 180 Medical Receives Award for High Integrity and Ethics

20 September 2016

• Independent survey of patient groups rates ConvaTec #1 overall for corporate reputation in the Medical Device industry
• ConvaTec U.S. subsidiary company 180 Medical receives Better Business Bureau recognition and named to Best Places to Work list by employees

LUXEMBOURG (20 September 2016) — ConvaTec, a leading global medical technology company, has the best corporate reputation in the medical device industry, according to a global survey of patient groups released today by Patient View, an independent UK-based research organization. In addition, ConvaTec U.S. subsidiary 180 Medical has received the Torch Award for Ethics from the Better Business Bureau of Central Oklahoma, and named one of the Best Places to Work in Oklahoma by OKC.biz for the seventh year.

ConvaTec has the overall top position in the Patient View survey, which was conducted with 582 patient advocacy groups from June-August 2016, and was rated number one in three of the seven categories used to measure corporate reputation. Overall, the company topped the list of 33 medical device companies, including Boston Scientific (second), Novo Nordisk (third), Coloplast (fourth), and Hollister (fifth).

“At ConvaTec, we exist to improve the lives of the people we touch,” said Symeria Hudson, President, Global Franchises and Innovation, ConvaTec. “These recognitions, coming from people who use and depend on our products and services every day, and from the community in which we live and work, mean a lot to everyone at ConvaTec and 180 Medical.”

“Across all of our franchises – ostomy care, advanced wound care, continence and critical care, and infusion devices – we are committed to helping people with chronic health conditions live the life they want, and giving them more mobility, confidence and freedom.”

“Patients are at the center of everything we do and, as the landscape of healthcare continues to evolve, now more than ever people with stomas and chronic conditions are beginning to demand more control over their condition and seeking more meaningful answers. At ConvaTec, we want to help drive this new attitude of empowerment as the future of care in the areas we serve.”

The Corporate Reputation of the Medical Device Industry, 2015-2016 – The Perspective of 582 Patient Groups

The Patient View survey, now in its fifth year, examines the reputation of the medical devices industry as a whole and provides individual ratings for medical device companies. This year’s survey was conducted with 582 patient groups, covering a wide range of specialties, from 62 countries.

Patient groups were asked to rate 33 companies across seven indicators of corporate reputation:

• Whether the company has an effective patient-centred strategy
• The quality of information the company provides to patients
• The company’s record on patient safety
• The usefulness to patients of the company’s products
• The company’s record of transparency with external stakeholders
• Whether the company acts with integrity
• The effectiveness of the company’s patient group relations

The 33 companies analyzed in the 2015-16 survey were:

3M Healthcare I Abbott Laboratories I Alcon I B. Braun Melsungen AG I Bausch + Lomb I Baxter International I BD (Becton, Dickinson and Company) I Biotronik International I Boston Scientific I Coloplast A/S I ConvaTec I Dansac I Fresenius Medical Care I GE Healthcare I Hartmann Group I Hitachi I Hollister I Invacare I Johnson & Johnson I Medtronic I Mölnlycke Health Care I Novo Nordisk A/S I Olympus Medical Business I Omron I Ortho Clinical Diagnostics I Philips Healthcare I Roche Diagnostics I Sanofi I Siemens Healthcare I Smith & Nephew I St Jude Medical I Stryker I Toshiba Medical Systems Corporation

For more information about the Patient View survey, visit www.patient-view.com

For more information about ConvaTec, visit www.convatec.com

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec’s products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. The company is owned by Nordic Capital and Avista Capital Partners.

# # #

© 2016 ConvaTec Inc.
All trademarks are property of their respective owners.
AP-016921-MM

 

Download PRESS RELEASE

 

 

 

 

Cookies are needed for this website to work optimally. They also help us to know a little bit about how you use our website, which improves the browsing experience.  Cookies on this site are used for traffic measurement and optimisation of page content only. By continuing to browse on this website, you indicate your consent to the use of cookies.  You may block the use of cookies by following the "How to block and avoid cookies" instructions

Learn more about our Cookie policy